Rate My Professor Kate Coffey

Dr Coffey's research specializations include human papillomavirus (HPV), cervical screening programs, genital tract diseases, and clinical risk management. She maintains memberships in professional societies such as the Australasian Society for Vulvovaginal Disease (ANZVS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the British Society for Colposcopy and Cervical Pathology (BSCCP). Notable publications co-authored by Dr Coffey feature investigations into gynaecological cancers and screening outcomes. These include "Vulvar cancer in high-income countries: Increasing burden of disease" published in the International Journal of Cancer in 2017, "Initial observation of CIN2 does not appear to reduce quality of life in women under 25 years of age" in the Australian & New Zealand Journal of Obstetrics & Gynaecology in 2017, and "Past cervical intraepithelial neoplasia grade 3, obesity, and earlier menopause are associated with an increased risk of vulval cancer in postmenopausal women" in the British Journal of Cancer in 2016. Further contributions cover the effects of obesity and hormone therapy on surgically-confirmed endometriosis (European Journal of Epidemiology, 2015) and the association between tubal ligation and incidence of 26 site-specific cancers in the Million Women Study (2016). Additionally, she presented "The cervix: A hidden gem" at the New Zealand Nurses Organisation Women's Health College Conference in 2021.